WhatsApp, WeChat & Telegram : +8801886229488, Email : aiopharma@outlook.com
Ponatinix (Ponatinib) 15/45 mg
Generic Name: Ponatinib
Manufacturer: Beacon pharma
Tablet: 30’s Pot / 60’s Pot
Originator: Iclusig by Ariad Pharma
Contact For Order:
WhatsApp & WeChat: +8801886229488
Email: aiopharma@outlook.com
WeChat QR Code
Ponatinib (Ponatinib) treats blood cancer, with an overall survival rate of 80.5%. Once daily convenient dose. ponatinix manufactured by beacon pharma.
FAQ about Ponatinix (Ponatinib)
Q: What is Ponatinix (Ponatinib) uses for?
It is a treatment for some types of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL).
Adjustable testosteron kaufen online Back Extension / Hyperextension bench, Panatta in Tessin acheter – Fitness and Service | tutti.ch mast test cycle fitness anal babe multiniche clips
Q: What generation is ponatinib?
Ponatinib: A Third-Generation Inhibitor for the Treatment of CML.
Q: Is ponatinib a chemotherapy drug?
Ponatinib is not a chemotherapy drug but one of many “targeted therapies.” About 100 years of research dedicated to understanding the differences between cancer cells and normal cells has resulted in targeted therapy.
Q: How effective is ponatinib?
The ponatinib initial daily dose was 45 mg in 60% of patients, 30 mg in 38% and 15 mg in 2% of patients. After a median time of 12 months, 85% of patients achieved a better molecular response compared with the baseline. Among them, 10 (40%) patients achieved a deep molecular response. We observed no AOEs (Table 2).
Product Description:
Ponatinix (Ponatinib), is an oral drug under the generic of Ponatinib, for the first-line therapy of the people affected with chronic myelogenous leukemia.
is a highly potential and multi-targeted third-generation Bcr-Abl tyrosine-kinase inhibitor (TKI). which is indicated for adult patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) or Ph+ALL for those who have no other TKI therapy.
It is also indicated for adult patients with T315I-positive CML (chronic phase, accelerated phase, or blast phase) or T315I-positive Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL).
Product Features:
Product Name | : | Ponatinix |
Generic Name | : | Ponatinib |
Formulation | : | Tablet |
Available Pack Size | : | 60’s pot |
Available Strength | : | 15 mg |
Registrations | : | Export Only |
Reviews
There are no reviews yet.